Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Preclinical Preclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
PreclinicalPreclinical and clinical research planning helps you bring forward the best emerging science to improve cancer diagnosis and treatment.
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Case Study
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Immuno-oncology therapies
Blog The Evolving Landscape of Oncology Drug Development Increasing incidence rates and the rise of novel therapies Oncology is the largest therapeutic area Read Now Photo of Keya Watkins and Sue Albert at the SITC sign during the SITC conference. Blog Key Insights from SITC 2024 Overcoming Cancer Resistance to Immunotherapy The Society for Immunotherapy of Cancer (SITC) is the premier Read Now Patient meeting with doctor who is taking notes with sunshine coming in from the background. Blog Highlights from HubXchange Immunotherapies Maryland 2024 Optimizing dose and leveraging biomarkers for enhanced patient safety in immunotherapy trials HubXchange Immunotherapies brought Read Now Antibody drug conjugates with blue cells Info Sheet Helping to Bring Antibody Drug Conjugates (ADCs) to Patients  Catalyst Oncology is a specialty oncology contract research organization (CRO) devoting time, energy, and capital Read Now Info Sheet Helping to Bring Cancer Therapies to Patients  Niche CRO with a difference Catalyst Oncology is a niche oncology CRO devoting time, energy, Read Now Info Sheet Helping to Bring Immunotherapies to Cancer Patients in Need Catalyst Oncology is a specialty oncology clinical research organization (CRO) devoting time, energy, and capital Read Now
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.